Register now for 4 October 2022 at 3:00pm -

October Investor Forum: Shareholder value in ESG investing
Life Sciences

Yourgene Health

Yourgene Health (YGEN) is an international molecular diagnostics group that uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests (NIPT). Its flagship IONA test uses complex statistical analyses to determine the likelihood that a fetus is carrying a genetic disorder, such as Down’s syndrome. YGEN has been held back by a patent infringement case and a complicated balance sheet. However, settlement of the patent case with Illumina and repayment of debt to Thermo Fisher (TMO) have transformed YGEN, allowing it to focus entirely on the enormous global growth opportunity for prenatal screening tests.

Market: AIM

Ticker: YGEN


Lead analyst: Dr Martin Hall

Request a meeting

If you'd like to be introduced to the team at Yourgene Health, get in touch.

Request a meeting